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INTRODUCTION
The a E-catenin protein, a component of the epithelial
cadherin/catenin adhesion complex, is a well-known invasion
suppressor. To reach full functionality of the cadherin/catenin
cell-cell adhesion complex, it is necessary to link the complex
to the actin cytoskeleton. a -Catenins provide this link by
binding to either b -catenin or plakoglobin through their N-
terminal domain, and by binding actin directly, through their
C-terminus, or indirectly, for example by binding to the actin-
binding molecule a -actinin (Rudiger, 1998). It has been shown
that loss of a E-catenin affects cell-cell adhesion and promotes
tumorigenicity (Ewing et al., 1995). In several invasive cells,
a E-catenin defects are observed, and introduction of
exogenous a E- or a N-catenin can restore cell-cell aggregation
and counteract invasiveness (Hirano et al., 1992; van Hengel
et al., 1997; Watabe et al., 1994). 
In contrast to the growing family of cadherins (Nollet et al.,
2000; Yagi and Takeichi, 2000), the family of a -catenins is so
far quite small. The a E-catenin protein is ubiquitously
expressed, mainly in epithelial tissues. a N-catenin shows
about 75% identity to a E-catenin, but its expression is
restricted to neural tissues (Hirano et al., 1992). By analogy
with a E-catenin, it can also bind to b -catenin or plakoglobin
and is supposed to bind a -actinin and actin. Although vinculin
shows much less identity (22%) to a E- or a N-catenin, it shares
some properties with a -catenins. Vinculin is mainly found
in focal adhesions, where it forms the link between the
extracellular matrix-binding integrins and the actin
cytoskeleton by binding to both the integrin-binding molecule
talin and to F-actin (Burridge and Mangeat, 1984). Vinculin is
sometimes found in cell-cell contacts as well, and it may even
be able to take over the function of a E-catenin by binding
directly to b -catenin (Hazan et al., 1997). However, vinculin
has been reported to bind to a central region of a E-catenin and
to be essential for apical junctional organization (Watabe-
Uchida et al., 1998). Moreover, vinculin contains a unique
central proline-rich hinge domain, which is absent in the a -
catenins and which allows the vinculin tail to bind to the head,
thus masking some binding sites (Johnson and Craig, 1995).
For the recently reported a -catulin (Janssens et al., 1999), the
identity to both a -catenins and vinculin is about 25% at the
amino acid level, but no functional evidence for adhesive
properties of a -catulin has yet been found. In addition to their
structural role, it is becoming clear that a -catenins and vinculin
also have a regulatory function in the coordination of assembly
and disassembly of adherens junctions (Rudiger, 1998). 
Here, we report on a novel a -catenin with about 55%
identity and 70% similarity to other a -catenins. We
demonstrate the tissue-specific expression of this a T-catenin
and its localization to cell-cell junctions of cardiomyocytes.
Moreover, testicular peritubular myoid cells are shown to
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Cadherins are major cell-cell adhesion proteins whose
cytoplasmic domains bind to catenin proteins. Strong
intercellular adhesion depends on linkage of the
cadherin/catenin complex to the actin cytoskeleton via a -
catenin. To date, it is not clear how different cell types
achieve the variable strength of cell-cell adhesion clearly
needed in a multicellular organism. Here, we report the
cloning and molecular characterization of a T(testis)-
catenin, a novel human cDNA encoding a protein with
homology to both human a E(epithelial)-catenin and
a N(neural)-catenin. Although originally discovered in
testis, a T-catenin is expressed in other tissues, the highest
levels being observed in heart. Immunohistochemical
analysis showed human a T-catenin localization at
intercalated discs of cardiomyocytes and in peritubular
myoid cells of testis. In cells transfected with a T-catenin
cDNA, interaction with b -catenin was demonstrated by co-
immunoprecipitation. Transfection of a -catenin-deficient
colon carcinoma cells recruited E-cadherin and b -catenin
to cell-cell contacts and functional cadherin-mediated
cell-cell adhesion was restored in this way. Moreover,
compaction of these cells was at least as prominent as in the
case of cells expressing endogenous a E-catenin. We
propose that a T-catenin is necessary for the formation of
stretch-resistant cell-cell adhesion complexes, in particular,
muscle cells.
Key words: Catenin, Cadherin, Muscle, Heart, Testis
SUMMARY
a T-Catenin: a novel tissue-specific b -catenin-binding
protein mediating strong cell-cell adhesion
Barbara Janssens1, Steven Goossens1, Katrien Staes1, Barbara Gilbert1, Jolanda van Hengel1,
Cecile Colpaert2, Erik Bruyneel3, Marc Mareel3 and Frans van Roy1,*
1Molecular Cell Biology Unit, Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology (VIB)-Ghent University,
B-9000 Ghent, Belgium
2Department of Pathology, University Hospital Antwerp (UZA), B-2650 Edegem, Belgium
3Department of Radiotherapy, Nuclear Medicine and Experimental Cancerology, University Hospital Ghent, B-9000 Ghent, Belgium
*Author for correspondence (e-mail: f.vanroy@dmb.rug.ac.be)
Accepted 28 May 2001
Journal of Cell Science 114, 3177-3188 (2001) © The Company of Biologists Ltd
RESEARCH ARTICLE
3178
express a T-catenin. Further, we prove that a T-catenin can
functionally restore cell-cell adhesion in colon cancer cells
lacking a -catenins. Together, these data indicate that this novel
a T-catenin is involved in the formation of specific cell-cell
contacts in particular types of muscle cells. 
MATERIALS AND METHODS
Cell cultures
Most of the cell lines used were purchased from the American Cell
Type Culture Collection (ATCC, Rockville, MD). HCT-8/E8, HCT-
8/E11R1 and HCT-8/R1 cell lines were obtained by subcloning of the
human ileocecal adenocarcinoma cell line HCT-8 (CCL-224), where
E stands for epithelioid and R for round-cell variants lacking a E-
catenin (van Hengel et al., 1997). PC-3 (CRL-1435) is a human
prostate carcinoma cell line and HEK-293 (CRL-1573) is a human
embryonic kidney fibroblast cell line. 
Cloning of human a T-catenin cDNA
A human a T-catenin-specific expressed sequence tag (EST) clone was
identified by BLAST analysis (Altschul et al., 1990) and requested
from the IMAGE consortium UK-HGMP Resource Center (Hinxton,
UK). Expression of the corresponding transcript was confirmed by
RT-PCR on PC-3 mRNA template using primers MCB967 (5 ¢ -
TGAGGCAGAAAAAGAAAAGA-3¢ ) and MCB968 (5 ¢ -AGTGT-
GGTTAGGCAGGATT-3 ¢ ). To complete the cDNA sequence we
performed two consecutive 5¢ MarathonTM RACE experiments on a
human testis Marathon cDNA preparation (Clontech, Palo Alto, CA).
For the first 5¢ RACE, the gene-specific primer was MCB1027 (5 ¢ -
AATCTGCCGAGCAAGGACATCCA-3 ¢ ) and the nested primer was
MCB1028 (5¢ -TCAGGCAGTTGAGTCATCTTAGC-3¢ ). RACE-PCR
was performed on a Perkin Elmer 2400 thermal cycler (Perkin Elmer,
Foster City, CA) following the supplied protocol (touchdown PCR).
Obtained RACE fragments were purified from agarose gel using
QIAquickTM columns (Qiagen, Chatsworth, CA) and then cloned in
the pGEMT Ò vector (Promega, Madison, WI). The resulting plasmid
was called pGEMT-haTctn-RACE1. As the cloned cDNA appeared to
be incomplete, a second 5 ¢ -RACE experiment was performed with
gene-specific primer MCB1254 (5 ¢ -ACCCGTGACGATGTGAGCA-
ACTC-3¢ ) and nested primer MCB1255 (5 ¢ -GAGCTGTCTGCGAA-
GGTCTCTTG-3¢ ). The obtained fragment was cloned in the
pGEMTÒ -easy vector (Promega), and called pGEMTeasy-haTctn-
RACE2. 
All DNA sequences were determined by the dideoxy chain
termination method (Sanger et al., 1977), using fluorescent dye
terminators in a 377ABI automated DNA sequencer (Applied
Biosystems, Foster City, CA). Sequences were assembled and
compared by use of the software packages DNAstar (DNASTAR,
Madison, WI) and Staden gap4 (Bonfield et al., 1995). Protein
alignments and amino acid similarities were calculated using the
CLUSTAL W program (Higgins and Sharp, 1989; Thompson et al.,
1994) and GCG software. Alignments were shaded using the WWW-
BOXSHADE server (http://ulrec3.unil.ch/softward/BOX_form.html). 
Expression analysis by RT-PCR
Expression analysis using the human Rapid-Scan panel (OriGene
Technologies, Rockville, MD) was performed on 100-times diluted
template, followed by nested PCR (1/10 of the end volume of the first
reaction was used). Primers MCB967 (5 ¢ -TGAGGCAGAAAAAG-
AAAAGA-3¢ ) and MCB968 (5 ¢ -AGTGTGGTTAGGCAGGATT-3¢ )
were used for the first PCR, yielding a product of 743 bp. For nested
PCR, primers MCB967 (5 ¢ -TGAGGCAGAAAAAGAAAAGA-3¢ )
and MCB1010 (5¢ -GCTGAGCCTCGTCTGAC-3¢ ) were combined,
yielding a smaller product of 630 bp. The end-point determination
method used does not allow a reliable determination of expression
levels to be deduced from the amount of PCR product visualized on
gel. Therefore, visual presence of a signal (even weak) was scored as
positive, and complete absence was scored as negative. As a control,
an a E-catenin-specific product of 747 bp was amplified with primers
MCB53 (5¢ -CTTCGGGCCTCTGGAATTTA-3¢ ) and MCB73 (5 ¢ -
CGACATCAGGGTGCTGTAGG-3¢ ). Amplified products were
checked for specificity by sequence analysis, showing that the double
bands observed for heart and testis after nested RT-PCR indeed
correspond to the larger primary product and the smaller nested
product predicted. 
For RT-PCR analysis of mouse tissues, RNA was prepared from
different tissues with the RNAeasy method (Qiagen) and cDNA was
prepared using a commercial kit (Life Technologies, Paisley, UK). For
mouse a T-catenin, primers MCB2461 (5 ¢ -CCCCAATGTTTT-ATGT-
TAT-3 ¢ ) and MCB2463 (5¢ -GGGGAGAACTCATCGTAT-3¢ ) were
designed on the sequence of an EST clone (GenBank accession no.
AW556211), resulting in amplification of a 442-bp product. For
mouse a E-catenin (GenBank accession no. NM_009818), a 733-bp
product was amplified with primers MCB2636 (5 ¢ -GAAGGCCC-
CTGAGAAGAA-3¢ ) and MCB2637 (5¢ -CCCGAATAAAGCAAC-
TCCAT-3 ¢ ). For mouse a N-catenin (GenBank accession no.
NM_009819) an 858-bp product was amplified with primers
MCB2479 (5¢ -GCCCTGATTGAGTTTGATAA-3¢ ) and MCB2480
(5¢ -CCCAGCTTCATAGTTCTCC-3 ¢ ). As a control, a 452-bp
fragment of mouse GAPDH was amplified with primers MCB2219
(5¢ -ACCACAGTCCATGCCATCAC-3 ¢ ) and MCB2220 (5¢ -TCCA-
CCACCCTGTTGCTGTA-3 ¢ ). 
Eukaryotic expression plasmids
After completion of plasmid constructs as described below, all clones
were checked by DNA sequencing. For all PCRs, Pfu polymerase
(Stratagene, La Jolla, CA) with proofreading activity was used. A
PCR product of 1134 bp was synthesized with primers MCB1607 (5 ¢ -
AGAATTCTCAGCTGAAACACCAATCAC-3 ¢ ) and MCB1609 (5¢ -
AGGATCCTGCGAAGGTCTCTTGTCT-3 ¢ ) using the pGEMTeasy-
haTctn-RACE2 clone as a template. This product, restricted with
EcoRI and PstI, was combined with a PstI-SspI fragment of pGEMT-
haTctn-RACE2, an SspI-BglII fragment from pGEMTeasy-haTctn-
RACE1, and a BglII-SalI fragment of a 3 ¢ overlapping PCR product
generated with primers MCB1610 (5 ¢ -GGATGATAATCAATTTGT-
GGACATCTC-3¢ ) and MCB1608 (5¢ -GGGATCCGTAGATTTG-
TCTTCCTCTAA-3¢ ) on RNA from the PC-3 prostate cancer cell line.
The full-length human a T-catenin cDNA was inserted in the EcoRI-
SalI-digested pEGFPC2 vector (Clontech), in order to obtain an in-
frame N-terminal fusion with the GFP protein. The resulting plasmid
was called pEGFPC2-haTctn(179-2860). An EcoRI-BstEII fragment
from clone pGEMT-RACE2 was combined with a BstEII-NotI
fragment of pEGFPC2-haTctnCTN(179-2860) in the EcoRI-NotI-
digested vector pEF6MycHisA (Invitrogen, San Diego, CA), yielding
construct pEF6MH-haTctn(1-2860) encoding a C-terminal fusion
between human a T-catenin and the Myc and His epitopes. 
Screening of a human fetal kidney 5¢ stretch cDNA library in vector
l DR2 (Clontech) with an a E-catenin-specific probe resulted in the
isolation of the pDR2 a ECTN plasmid, from which an Eco47III-SalI
fragment corresponded to the full-length a E-catenin cDNA (GenBank
accession no. D14705). The latter fragment was purified and ligated
in the EcoRI-SalI-digested pEGFPC2 vector (Clontech), yielding
plasmid pEGFPC2-haEctn(69-3454). 
A full-length cDNA fragment of human a N-catenin (GenBank
accession No. M94151) was prepared from plasmid pPN-hANCTN
(Claverie et al., 1993), kindly provided by C. Petit (Institut Pasteur,
Paris). This fragment was then cloned in the EcoRI-SalI-digested
pEGFPC2 vector (Clontech), yielding plasmid pEGFPC2-haNctn(39-
2885). 
Transfection experiments
For vaccinia virus-mediated transient overexpression, a -catenins were
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cloned in the pE/L-GFP vector (Frischknecht et al., 1999). Cells were
transfected with Lipofectin (Life Technologies) and simultaneously
co-infected with vaccinia virus strain D A36R, which does not make
actin tails (Parkinson and Smith, 1994). At 4 to 30 hours after
transfection, high levels of expression under control of the vaccinia
virus early/late promoter (E/L) (Chakrabarti et al., 1997) were
obtained of the cloned cDNA, N-terminally fused to GFP. To this end,
human a T-catenin cDNA was amplified with Taq+Precision
polymerase (Stratagene) using primers containing a 5 ¢ NotI site and a
3¢ EcoRI site (MCB2386, 5 ¢ -GGGGGCGGCCGCGGAGGGTCA-
GCTGAAACACCAATCACATTG-3 ¢ and MCB2387, 5¢ -CCCCG-
AATTCGCCGTGTGGTTAGGCAGGATTTTGTCATATAG-3¢ ) and
cloned into the NotI-EcoRI sites of the pE/L-GFP vector, yielding
plasmid pE/L-GFP-haTctn(179-2913). 
HEK-293 cells were transiently transfected by the calcium
phosphate method. For stable transfection of HCT-8/R1 carcinoma
cells, 4· 106 cells were electroporated (Easyject; Eurogentec, Seraing,
Belgium) with 10 m g of plasmid pEF6MH-haTctn(1-2860). Cells
were plated and cultured in the presence of 6 m g/ml blasticidin
(Invitrogen) to select for stable transfectants. Colonies of blasticidin-
resistant cells were isolated and tested by immunofluorescence and
western blotting for expression of a T-catenin. One positive clone
was isolated and called HCT-8/R1/T31. As a negative control we
transfected HCT-8/R1 cells with the empty pEF6MH vector, resulting
in stable clones called HCT-8/R1/1743. As reported previously (van
Hengel et al., 1997), related HCT-8/E11R1 cells were stably
transfected with a N-catenin cDNA and a positive clone was
designated HRpC a N2.
Antibodies
For the generation of polyclonal antibodies, peptide #952 with
sequence C-KIHPLQVMSEFRGRQIY, corresponding to the C-
terminus of the human a T-catenin protein, was coupled to keyhole-
limpet hemocyanin (Sigma, St Louis, MO) and injected into each of
three rabbits using Titermax (Sigma) as adjuvant. Boosts were given
with intervals of minimum two weeks. Sera were tested by ELISA on
the peptide used for injection, using nonrelevant peptide as a negative
control. For western blotting, a dilution of 1:1000 was used and
recognition of a T-catenin was inhibited by incubation of the
polyclonal antibody in blocking solution containing 0.5 to 2.5%
antigenic peptide for 1 hour prior to use. 
Monoclonal antibodies were generated by coupling N-terminal
peptide #892, with sequence C-VANKSDLQKTYQKL, to keyhole-
limpet hemocyanin, followed by injection into C57Bl/6 mice. Boosts
were given with intervals of 2 weeks, and sera were tested by peptide-
ELISA until a titer of 1:10,000 without loss of reactivity was obtained
after 6 weeks. Hybridomas were generated by fusion of spleen cells
with Sp20_Ag14 myeloma cells. Supernatants of hybridoma cell
lines, positive in peptide-ELISA, were tested by western blotting and
immunofluorescence for recognition of the a T-catenin protein, fused
at its N-terminus to GFP, in lysates of various cells transfected with
plasmid pEGFPC2-haTctn(179-2860). One hybridoma cell line,
designated 892_24D2S after subcloning, was deposited with the
Belgian Coordinated Collections of Microorganisms (BCCMTM) (no.
LMBP 5537CB) and used for further analysis.
Other primary antibodies used were polyclonal aE -catenin- and b -
catenin-specific antibodies (Sigma), monoclonal a E-catenin- and b -
catenin-specific antibodies (Transduction, Lexington, KY), anti-E-
cadherin monoclonal antibodies HECD-1 (Takara Biochemicals,
Otsu, Japan) and MB2 (Bracke et al., 1993), anti-N-cadherin
monoclonal antibody (Zymed, San Francisco, CA), monoclonal anti-
desmin antibody clone 33 (Biogenex, San Ramon, CA), anti-
desmoglein clone 10G11 (Progen, Heidelberg, Germany), anti-ZO-1
(Zymed) and anti-Myc-tag clone 9E10 (Oncogene, Cambridge, MA).
SDS-PAGE and western blot analysis
Protein lysates from various mouse tissues were prepared by isolating
the tissues from normal BALB/c mice and mixing them in Laemmli
buffer (Laemmli, 1970). Debris was removed by centrifugation and
protein concentration was measured by the BioRad DC kit (BioRad,
Richmond, CA). Lysates from subconfluent cultures of cell lines were
also prepared in Laemmli buffer, followed by sonication and
centrifugation. Of each protein lysate, 40 m g was diluted with 6· sample
buffer (0.35 M Tris-HCl, pH 6.8, 10.28% SDS, 36% glycerol, 5% b -
mercaptoethanol, 0.012% bromophenol blue), boiled for 5 minutes and
subjected to separation on 10% polyacrylamide gels. Proteins were
transferred onto Immobilon-P membranes (Millipore, Bredford, MA)
and blocked with 5% nonfat dry milk, 0.1% Tween-20 in Tris-buffered
saline buffer (100 mM Tris-HCl, pH 7.4, 1.4 M NaCl) prior to
incubation with the primary antibody. Detection was carried out by
phosphatase-coupled secondary antibodies (Sigma) and nitroblue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) as a
substrate.
For co-immunoprecipitation, lysates of transfected HEK-293 cells
were prepared in PBS containing 1% Nonidet P-40 and a protease
inhibitor cocktail (Boehringer). Lysates of mouse tissues were
prepared in extraction buffer containing 25 mM Tris/HCl (pH 7.5), 1
mM EDTA, 1 mM EGTA, 100 mM NaCl, 1% Triton X-100, 0.5%
Nonidet P-40 and the protease inhibitor cocktail. Lysate (800 m g) was
incubated overnight with 4 m g of the respective antibody, after which
100 m l of 50% protein-G Sepharose (Amersham Pharmacia Biotech,
Rainham, UK) was added to monoclonal antibodies, whereas protein-
A Sepharose (Amersham Pharmacia Biotech) was added to polyclonal
antibodies. After 2 hours of incubation, the Sepharose beads were
washed three times with PBS containing 0.1% Nonidet P-40, followed
by boiling for 5 minutes in Laemmli buffer. Samples were split in two
parts before being subjected to SDS-PAGE and western blotting. On
these western blots, protein was detected by the ECL detection system
using secondary antibodies coupled to horseradish peroxidase
(Amersham Pharmacia Biotech). 
Immunodetection in cryosections of human tissues
For immunohistochemistry, frozen sections of human heart and testis
tissues were air dried and fixed in aceton at 4°C for 10 minutes. The
sections were washed in PBS and preincubated with 10% goat serum
for 10 minutes. They were then incubated for 30 minutes with crude
monoclonal 892_24D2S hybridoma supernatant, which was diluted in
PBS with 1% BSA, or with clone 33 anti-desmin antibodies. The
secondary antibody used was biotin-labeled goat-anti-mouse Ig
(Dako, Carpinteria, CA), which was subsequently linked to
streptavidin-biotin complex coupled to horseradish peroxidase.
Detection was carried out by a 5-minute incubation with the
chromogenic peroxidase substrate diaminobenzidine (Biogenex). Cell
nuclei were counterstained with hematoxylin, after which the slides
were dehydrated in alcohol, cleared in toluol and mounted. 
For double immunofluorescent staining, frozen sections were air
dried, fixed in acetone at 4°C for 10 minutes, washed in PBS and
preincubated with 10% goat serum for 10 minutes. The slides were
then incubated for 45 minutes with mixtures of primary antibodies
diluted in PBS: either 1:5 monoclonal antibody 892_24D2S plus
1:500 polyclonal anti- a E-catenin, or 1:500 polyclonal antibody #952
plus 1:500 monoclonal anti-N-cadherin. The secondary goat anti-
mouse IgG and goat anti-rabbit IgG antibodies used were labeled with
FITC or TRITC (Santa Cruz Biotechnology, Santa Cruz, CA), or with
Alexa 488 or Alexa 594 (Molecular Probes, Eugene, OR). 
Immunocytochemistry of cell cultures 
Cells were grown on glass coverslips until confluency, rinsed briefly
with PBS and fixed with either ice-cold methanol for 1 minute, or with
3% paraformaldehyde (Merck, Darmstadt, Germany) for 10 minutes
at room temperature, followed by permeabilization in 0.2% Triton X-
100 (Sigma) for 2 minutes. Cells were then incubated for 30 minutes
with primary antibody diluted in blocking solution (20 mM Tris/HCl
pH 7.5, 154 mM NaCl, 2 mM EDTA, 2 mM MgCl2, with 1% BSA
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Fig. 1. Sequence comparison
between the novel a T-catenin
and other members of the human
a -catenin/vinculin family.
(A) Alignment of the protein
sequences by the CLUSTAL W
method (Higgins and Sharp,
1989). The location of N-
terminal a -helices as determined
for a E-catenin (Pokutta and
Weis, 2000) is shown on top of
the sequences. Only one of two
characteristic proline residues,
inducing kinks in the a -helices
of a E-catenin (marked with P
below the sequences) is
conserved in a T-catenin. Other
annotated domains of a E-catenin
are: b -catenin-binding domains
(Pokutta and Weiss, 2000; Huber
et al., 1997), the a -actinin-
binding domain (Nieset et al.,
1997), amphiphatic helices
possibly responsible for actin
binding (Rudiger, 1998). Also
indicated is the position of an alternatively spliced
insert generally found for a N-catenin (Claverie et
al., 1993). The sequences aligned here are
available from GenBank under accession nos.
AF091606 (a T-catenin), D14705 ( a E-catenin) and
M94151 (a N2-catenin). (B) Schematic protein
alignments including amino acid identities (%)
between the three main vinculin homology
domains (black boxes) (Herrenknecht et al., 1991).
As reported before (Janssens et al., 1999), a -
catulin and vinculin are clearly more distant
members of the a -catenin/vinculin family. The
total size of the depicted proteins is indicated at the
right (aa, amino acid residues), whereas residues
flanking various domains are indicated by their
codon numbers. N, amino-terminus; C, carboxy-
terminus. 
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B
A
                                                                        ì        a -helix-0       
h a T-ctn    1  MSA..ETPITLNIDPQDLQVQTFTVEKLLEPLIIQVTTLVNCPQN.PSSRKKGRSKRASVLLASVEEATWNLLDKGEKIA 
h a E-ctn    1  MTAVHAGNINFKWDPKSLEIRTLAVERLLEPLVTQVTTLVNTNSKGPSNKKRGRSKKAHVLAASVEQATENFLEKGDKIA 
h a N2-ctn   1  MTSA.TSPIILKWDPKSLEIRTLTVERLLEPLVTQVTTLVNTSNKGPSGKKKGRSKKAHVLAASVEQATQNFLEKGEQIA 
                                                                        î     b -ctn binding      
 
                ü     ì          a -helix-1        ü    ì     a -helix-2a     ü ì     a -helix-2b    
h a T-ctn   78  QEATVLKDELTASLEEVRKESEALKVSAERFTDDPCFLPKREAVVQAARALLAAVTRLLILADMIDVMCLLQHVSAFQRT 
h a E-ctn   81  KESQFLKEELVAAVEDVRKQGDLMKAAAGEFADDPCSSVKRGNMVRAARALLSAVTRLLILADMADVYKLLVQLKVVEDG 
h a N2-ctn  80  KESQDLKEELVAAVEDVRKQGETMRIASSEFADDPCSSVKRGTMVRAARALLSAVTRLLILADMADVMRLLSHLKIVEEA 
                                                         b -ctn binding  þ           
 
                  ü     ì           a -helix-3         ü   ì            a -helix-4          ü   ì  
h a T-ctn  158  FETLKNVANKSDLQKTYQKLGKELENLDYLAFKRQQDLKSPNQRDEIAGARASLKENSPLLHSICSACLEHSDVASLKAS 
h a E-ctn  161  ILKLRNAGNEQDLGIQYKALKPEVDKLNIMAAKRQQELKDVGHRDQMAAARGILQKNVPILYTASQACLQHPDVAAYKAN 
h a N2-ctn 160  LEAVKNATNEQDLANRFKEFGKKMVKLNYVAARRQQELKDPHCRDEMAAA GALKKNATMLYTASQAFLRHPDVAATRAN 
                                   î P þ                                   î P þ           
                     a -helix-5   ü  
h a T-ctn  238  KDTVCEEIQNALNVISNASQGI..QNMTTPPEPQAATLGSALDELENLIVLNPLTVTEEEIRPSLEKRLEAIISGAALLA 
h a E-ctn  241  RDLIYKQLQQAVTGISNAAQATASDDASQHQGGGGGELAYALNNFDKQIIVDPLSFSEERFRPSLEERLESIISGAALMA 
h a N2-ctn 240  RDYVFKQVQEAIAGISNAAQATSPTDEAKGHTGIG.ELAAALNEFDNKIILDPMTFSEARFRPSLEERLESIISGAALMA 
 
 
h a T-ctn  316  DSSCTRDLHRERIIAECNAIRQALQDLLSEYMNNAGKKERSNTLNIALDNMCKKTRDLRRQLRKAIIDHVSDSFLDTTVP 
h a E-ctn  321  DSSCTRDDRRERIVAECNAVRKALQDLLSEYMGNAGRKERSDALNSAIDKMTKKTRDLRRQLRKAVMDHVSDSFLETNVP 
h a N2-ctn 319  DSSCTRDDRRERIVAECNAVRQALQDLLSEYMNNTGRKEKGDPLNIAIDKMTKKTRDLRRQLRKAVMDHISDSFLETNVP 
                   î                    a -actinin binding                                 þ  
 
h a T-ctn  396  LLVLIEAAKNGREKEIKEYAAIFHEHTSRLVEVANLACSMSTNEDGIKIVKIAANHLETLCPQIINAALALAARPKSQAV 
h a E-ctn  401  LLVLIEAAKNGNEKEVKEYAQVFREHANKLIEVANLACSISNNEEGVKLVRMSASQLEALCPQVINAALALAAKPQSKLA 
h a N2-ctn 399  LLVLIEAAKSGNEKEVKEYAQVFREHANKLVEVANLACSISNNEEGVKLVRMAATQIDSLCPQVINAALTLAARPQSKVA 
 
 
h a T-ctn  476  KNTMEMYKRTWENHIHVLTEAVDDITSIDDFLAVSESHILEDVNKCIIALRDQDADNLDRAAGAIRGRAARVAHIVTGEM 
h a E-ctn  481  QENMDLFKEQWEKQVRVLTDAVDDITSIDDFLAVSENHILEDVNKCVIALQEKDVDGLDRTAGAIRGRAARVIHVVTSEM 
h a N2-ctn 479  QDNMDVFKDQWEKQVRVLTEAVDDITSVDDFLSVSENHILEDVNKCVIALQEGDVDTLDRTAGAIRGRAARVIHIINAEM 
 
 
h a T-ctn  556  DSYEPGAYTEGVMRNVNFLTSTVIPEFVTQVNVALEALSKSSLNVLDDNQFVDISKKIYDTIHDIRCSVMMIRTPEELED 
h a E-ctn  561  DNYEPGVYTEKVLEATKLLSNTVMPRFTEQVEAAVEALSSDPAQPMDENEFIDASRLVYDGIRDIRKAVLMIRTPEEL.D 
h a N2-ctn 559  ENYEAGVYTEKVLEATKLLSETVMPRFAEQVEVAIEALSANVPQPFEENEFIDASRLVYDGVRDIRKAVLMIRTPEELED 
 
 
h a T-ctn  636  VSDLEEEH.EVRSHTSIQTE......GKTDRAKMTQLPEAEKEKIAEQVADFKKVKSKLDAEIEIWDDTSNDIIVLAKNM 
h a E-ctn  640  DSDFETEDFDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQM 
h a N2-ctn 639  DSDFEQEDYDVRRGTSVQTEDDQLIAGQSARAIMAQLPQEEKAKIAEQVEIFHQEKSKLDAEVAKWDDSGNDIIVLAKQM 
 
 
h a T-ctn  709  CMIMMEMTDFTRGKGPLKHTTDVIYAAKMISESGSRMDVLARQIANQCPDPSCKQDLLAYLEQIKFYSHQLKICSQVKAE 
h a E-ctn  720  CMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHHLNICSKVKAE 
h a N2-ctn 719  CMIMMEMTDFTRGKGPLKNTSDVINAAKKIAEAGSRMDKLARAVADQCPDSACKQDLLAYLQRIALYCHQLNICSKVKAE 
                                   î     amphiphatic helices    þ  
 
h a T-ctn  789  IQNLGGELIMSA................................................LDSVTSLIQAAKNLMNAVVQ 
h a E-ctn  800  VQNLGGELVVSG................................................VDSAMSLIQAAKNLMNAVVQ 
h a N2-ctn 799  VQNLGGELIVSGTGVQSTFTTFYEVDCDVIDGGRASQLSTHLPTCAEGAPIGSGSSDSSMLDSATSLIQAAKNLMNAVVL 
                           î           alternatively spliced insert         þ             
 
h a T-ctn  821  TVKMSYIASTKIIRIQSPAGPRHPVVMWRMKAPAKKPLIKREKPEETCAAVRRGSAKKKIHPLQVMSEFRGRQIY 893 
h a E-ctn  832  TVKASYVASTKYQKSQGMASLNLPAVSWKMKAPEKKPLVKREKQDETQTKIKRASQKKHVNPVQALSEFKAMDSI 906 
h a N2-ctn 879  TVKASYVASTKYQKVYGTAAVNSPVVSWKMKAPEKKPLVKREKPEEFQTRVRRGSQKKHI........FACTGFK 946 
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and 1% goat serum), washed in PBS, and incubated for 30 minutes
with secondary antibodies diluted in blocking solution. Secondary
anti-mouse IgG or anti-rabbit IgG antibodies were coupled to either
Alexa 594 or Alexa 488 (Molecular Probes). Finally, cells were
treated for 10 seconds with a 4 ¢ -6-diamidine-2-phenylindole-
dihydrochloride solution (DAPI; Roche Diagnostics, Mannheim,
Germany) to mark nuclear DNA, followed by mounting in Vectashield
(Vector Laboratories, Burlingame, CA) to prevent photobleaching.
Samples were examined with a Zeiss Axiophot microscope and
images were recorded with a high-performance charge-coupled digital
camera (Cohu, San Diego, CA) and NIH image software (version
1.62), or with a MicroMAX camera (Princeton, Trenton, NJ) and
MetaMorph software (Image Universal Corporation, New York, NY).
Aggregation assays
Cell-cell adhesion was numerically evaluated in a fast aggregation
assay as described before (Bracke et al., 1993). In brief, cultures were
dissociated into single-cell suspensions under E-cadherin-saving
conditions using collagenase. They were incubated under Gyrotory
shaking (New Brunswick Scientific, New Brunswick, NJ) at 80 rpm
for 30 minutes in an isotonic buffer containing either 1 mM EGTA or
1.25 mM Ca2+. E-cadherin could be functionally blocked by treatment
with MB2 anti-cadherin monoclonal antibody, starting 30 minutes
before aggregation at 4 ° C and continued
throughout aggregation at 37 ° C. The volume
distribution (expressed as % of the total cell
volume) in function of the particle diameter
was measured by an LS200 particle size
analyzer (Coulter Electronics Ltd, Luton, UK),
at the start of the incubation at 37 ° C (t0) and
after 30 minutes (t30). The Kolmogoronov-
Smirnov test was applied to cumulative fast
aggregation curves to analyze statistical
differences.
Slow aggregation was performed as described (Boterberg et al.,
2000). Briefly, single-cell suspensions were seeded onto a semi-solid
agar medium. After 24 hours, aggregate formation was evaluated
subjectively by phase-contrast microscopy. 
For the compaction and decompaction assays, cells were seeded at
a density of 6 · 105 cells/6 ml of RPMI supplemented with 10% fetal
bovine serum. The suspended cells were incubated on a Gyrotory
shaker (New Brunswick, NJ) at 80 rpm for 3 days. Aggregate
formation was evaluated, after which the multicellular spheroids were
dissociated by passing 30 times through Pasteur pipettes with a
diameter of 1.5 mm (Takeda et al., 1995). Compaction and
decompaction were evaluated qualitatively by phase-contrast
microscopy and quantitatively by measuring the volume distribution
(% of total cell volume) in function of the particle diameter using an
LS200 particle size analyzer (Coulter). 
RESULTS
Isolation of a novel a -catenin cDNA
By performing BLAST analyses (Altschul et al., 1990) with
a E-catenin sequences as a query, two human EST sequences
Fig. 2. Tissue-specific expression patterns of
a T-catenin. (A) Rapid-scan RT-PCR
expression analysis of human a T-catenin and
a E-catenin mRNAs. The specific 743-bp
product of the first reaction was visible in
heart, testis and skeletal muscle (not shown).
After nested PCR, this first product of 743 bp
is still visible, whereas the nested PCR
product of 630 bp is detectable in the same
three samples and a few more (brain, kidney,
liver, fetal liver). PCR with a E-catenin-
specific primers (yielding a 747-bp product)
reveals expression in most tissues. PBL,
peripheral blood lymphocytes. (B) RT-PCR
analysis of a E-catenin, a T-catenin and a N-
catenin mRNAs in mouse organs. GAPDH
mRNA analysis served as a positive control.
(C) Western blot analysis of a T-catenin, a E-
catenin and b -catenin protein expression in
various mouse organs. For detection of a T-
catenin, polyclonal serum #952 was applied.
In brain tissue, the 104-kDa band revealed by
anti- a E-catenin most likely corresponds to
crossreacting a N2-catenin protein.
(D) Antibody specificity was tested by
western blot analysis of HEK-293 cells
transfected with GFP-tagged a -catenins: a
commercial a E-catenin antibody (Sigma)
crossreacts with a N-catenin but not with a T-
catenin, whereas serum #952 is highly specific
for a T-catenin.
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(GenBank accession nos. AA393647 and AA400832), both
originating from IMAGE clone 728263, were found to be
similar but not identical to a E- or a N-catenin. By RT-PCR, we
confirmed faint expression of this novel transcript in the a E-
catenin-negative prostate carcinoma cell line PC-3 (data not
shown). Two consecutive 5 ¢ RACE experiments using human
testis mRNA as a template provided us with a full-length
cDNA sequence (GenBank accession no. AF091606). The
3024 bp sequence contains a Kozak-consensus start codon
(Kozak, 1991) at position 176, preceded by an in-frame stop
codon at position 137. The stop codon terminating the ORF is
located at position 2861, and a putative poly-adenylation signal
(ATAAAA) is seen in the 3 ¢ untranslated region 38 bp before
the end of the sequence. The ORF encodes a protein of 895
amino acid residues, with a predicted molecular weight of 100
kDa and an overall identity to a E-catenin (102 kDa) and
a N-catenin (104 kDa) of about 58% and 56%, respectively
(Table 1; Fig. 1). Homology with either vinculin or a -catulin
(Janssens et al., 1999) was significantly lower. Thus, we
considered this novel molecule a true a -catenin family
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Fig. 3. Immunolocalization of a T-
catenin in cryosections of human
heart. (A) Double
immunofluorescent staining of a T-
catenin (monoclonal antibody
892_24D2S) and a E-catenin
(polyclonal antibody) shows
colocalization of the a -catenin
proteins at intercalated discs of
cardiomyocytes. (B) Double
immunofluorescent staining of a T-
catenin (polyclonal antibody #952)
and N-cadherin (monoclonal
antibody) shows colocalization at
intercalated discs of
cardiomyocytes.
(C) Immunohistochemical staining
for a T-catenin (monoclonal
antibody 892_24D2S) or desmin
(monoclonal antibody 33) shows
that a T-catenin is localized at the
intercalated discs of
cardiomyocytes, while desmin is
present also at Z-discs. In the
negative control (neg), only
secondary antibody was used.
Fig. 4. Immunolocalization of a T-
catenin in cryosections of human
testis. (A) Double
immunofluorescent staining of
a T-catenin (monoclonal antibody
892_24D2S) and a E-catenin
(polyclonal antibody) shows
differential localization of these
two related proteins. The a T-
catenin is present in peritubular
cells, clearly separated from a E-
catenin, which is present in cells
within the seminiferous tubules.
(B) Immunohistochemical
staining of consecutive sections
for a T-catenin (monoclonal
antibody 892_24D2S) and desmin (monoclonal antibody 33) demonstrates that a T-catenin is localized in desmin-expressing peritubular myoid
cells. In the negative control (neg), only secondary antibody was used.
3183Novel tissue-specific a T-catenin
member, and designated it a T-catenin because its transcript
was discovered in a testis-derived cDNA library.
a T-catenin is highly expressed in heart and testis
A human cDNA Rapid Scan panel was screened by PCR for
a T-catenin expression. A first PCR reaction revealed
expression in mainly heart and testis (data not shown), whereas
a second nested PCR also amplified low amounts in some
additional tissues such as brain, kidney, liver (adult and fetal)
and skeletal muscle (Fig. 2A). Compared with the ubiquitously
expressed a E-catenin, the novel a T-catenin shows a very
restricted expression pattern (Fig. 2A). These findings were
confirmed by RT-PCR analysis of several mouse tissues (Fig.
2B). The brain-specific expression of mouse a N-catenin
mRNA is in line with the literature (Hirano et al., 1992).
Polyclonal and monoclonal antibodies were generated against
peptides derived from, respectively, the C- and the N-terminus
of human a T-catenin. Upon analysis of several mouse tissue
lysates by western blotting, we observed a specific cross-species
reaction of polyclonal serum #952 with mouse a T-catenin (Fig.
2C). The highest expression of mouse a T-catenin protein was
found in heart, but testis, ovary, uterus and tongue also scored
positive. Low amounts were seen in brain, lung, skeletal muscle
and thymus. The same mouse multiple tissue blot was incubated
with antibodies specific for a E- and b -catenin. Both proteins
were expressed ubiquitously. Compared with a T-catenin, a E-
catenin protein levels seemed to be lower in heart and testis, but
higher in kidney, liver, lung and thymus (Fig. 2C). The
specificity of the a -catenin antibodies used was shown on lysates
of HEK-293 cells transfected with the respective GFP-tagged a -
catenin constructs (Fig. 2D). A commerical ‘a E-catenin’
antibody crossreacted with a N-catenin but not with a T-catenin,
whereas polyclonal antibody #952 turned out to be specific for
a T-catenin. The latter interaction with a T-catenin on western
blot could be abolished by preincubation of antibody #952 with
the immunizing peptide. 
We then investigated the localization of a T-catenin protein
in frozen tissue sections of human heart and testis. In human
cardiomyocytes, a T-catenin protein was clearly located at cell-
cell contacts (i.e. intercalated discs; Fig. 3). In double labelling
experiments, it co-localized with a E-catenin (Fig. 3A) as well
Fig. 5. Confirmation of a T-catenin/b -catenin interactions by co-
immunoprecipitation (IP). (A) IP from HEK-293 cells transfected
with a plasmid encoding Myc-tagged a T-catenin. In the western
blots (left), which serve as controls for efficient transfection, a T-
catenin was detected by monoclonal antibody 892_24D2S and b -
catenin by a polyclonal antibody. The IP results (right) were obtained
either with monoclonal anti-b -catenin antibody or with monoclonal
anti-Myc antibody. SDS-PAGE was followed by western blotting. A
mixture of both antibodies was then used to probe this blot. In mock
transfected cells, only b -catenin was detected as expected (data not
shown). (B) IP from mouse tissues, performed with polyclonal
antibody #952, specific for a T-catenin, and a polyclonal antibody
specific for b -catenin (Sigma). After western blotting of total lysates
(left) and coimmunoprecipitates (right), a T-catenin and b -catenin
were detected by use of the same antibodies. 
Fig. 6. Transient overexpression
of a T-catenin in a -catenin-
negative HCT-8/R1 colon
carcinoma cells restores
cadherin/catenin-mediated cell-
cell adhesion. At 10 hours after
transfection with pE/L-GFP-
haTctn plasmid and
simultaneous infection with
D A36R vaccinia virus, opposing
cells expressing GFP-a T-catenin
show increased fluorescence at
their common cell-cell contacts
(A). This results in recruitment
of b -catenin and E-cadherin to
the same intercellular contact
sites (B). 
Table 1. Percentage of identities (and similarities) of
members of the a -catenin/vinculin family*
Vinculin a -Catulin a T-Catenin a E-Catenin a N-Catenin
Vinculin 100 18.6 (23.7) 17.3 (30.3) 22.5 (31.0) 22.3 (30.0)
a -Catulin 100 19.7 (32.1) 24.8 (33.9) 25.6 (32.8)
a T-Catenin 100 56.1 (73.7) 58.5 (69.6)
a E-Catenin 100 76.5 (83.1)
a N-Catenin 100
*MegAlign sequence comparison and distance calculation with GCG
software (http://www.BEN.ac.be). Aligned sequences are available from
GenBank under accession nos. M33308 (vinculin), U97067 ( a -catulin),
AF091606 (a T-catenin), D14705 ( a E-catenin) and M94151 ( a N2-catenin).
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as N-cadherin (Fig. 3B). The muscle marker desmin could be
detected at both intercalated discs and sarcomeric Z-lines,
whereas a T-catenin expression was confined to intercalated
discs (Fig. 3C). In human testis, a T-catenin protein was
detected mainly in spindle-shaped cells surrounding testicular
tubuli (Fig. 4). Interestingly, a T-catenin did not co-localize
here with a E-catenin, as the latter showed an abundant
intratubular expression pattern (Fig. 4A). The a T-catenin-
expressing cells in testis correspond to desmin-positive cells
(Fig. 4B), and therefore could be identified as peritubular
myoid cells. These stainings suggest that a T-catenin
expression is confined to specific muscle cell types, although
detailed immunohistological studies of additional tissues are
warranted in this respect. 
a T-catenin interacts with b -catenin
and functionally restores cell
aggregation in a -catenin-negative
cancer cells
The localization of a T-catenin at particular
cell-cell contacts suggests an interaction
between a T-catenin and the cadherin/catenin
complexes. Interaction between a T-catenin
and b -catenin was confirmed by
coimmunoprecipitation either from lysates
of HEK-293 cells overexpressing Myc-
tagged a T-catenin, or from mouse heart and
testis tissue extracts (Fig. 5). 
To assess whether a T-catenin binding to
b -catenin has functional implications for the
formation of cell-cell contacts, we carried
out rescue experiments by overexpression of
a T-catenin in round HCT-8/R1 cells lacking
a -catenins (Vermeulen et al., 1995;
Vermeulen et al., 1999). Vaccinia virus-
mediated expression was used to obtain high
transient transfection efficiencies (30-70%).
Cell-cell adhesion was found to be restored
if neighboring cells expressed the ectopic
protein that became enriched at cell-cell
contacts, whereas solitary expressing cells
remained round with diffuse expression of
the ectopic protein (Fig. 6A). Moreover,
when GFP-tagged a T-catenin was
overexpressed in neighboring cells, its
enrichment in cell-cell contacts recruited
both b -catenin and E-cadherin to these sites
(Fig. 6B). However, when a T-catenin was
overexpressed for longer time periods, it
tended to form cytoplasmic rod-like
aggregates (data not shown). 
To quantify the restoration of cell-cell
adhesion by a T-catenin expression in HCT-
8/R1 cells, these cells were transfected with
a plasmid encoding Myc-tagged a T-catenin.
Using polyclonal antibody #952, one
transfectant was found to express ectopic
a T-catenin and called HCT-8/R1/T31.
Immunofluorescent analysis of HCT-
8/R1/T31 cells with anti-Myc antibodies
showed that the a T-catenin-Myc protein
was localized at restored cell-cell contacts (Fig. 7). Components
of the adherens junctions (E-cadherin, b -catenin and
plakoglobin) were recruited to such a T-catenin-positive sites,
but desmosomes (desmoglein-2) and tight junctions (ZO-1,
occludin) also showed reassembly (Fig. 7). 
By using the fast aggregation assay, we showed that HCT-
8/R1/T31 cells are strongly aggregating, in contrast to
nonaggregating parental HCT-8/R1 cells (Fig. 8). HCT-
8/R1/T31 cells aggregated to an extent similar to that of a E-
catenin-positive HCT-8/E8 cells and HRpC a N2 cells
transfected with a N-catenin cDNA. These differences were
significant (Table 2), showing that a T-catenin can functionally
restore aggregation. 
In a slow aggregation assay, a T-catenin-transfected HCT-
8/R1/T31 cells were compacting to the same extent as a E-
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Fig. 7. Relocalization of multiple cell-cell adhesion components in stably transfected colon
cancer cells, expressing Myc-tagged a T-catenin. The a -catenin-negative parental HCT-
8/R1 cells (left panels) were compared to the cloned transfectant HCT-8/R1/T31 (right
panels). Cells were stained for the Myc tag (exogenous a T-catenin), for E-cadherin,
desmoglein-2 or ZO-1 antigens.
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catenin-positive HCT-8/E8 cells (Fig. 9B). In a quantitative
compaction/decompaction assay (Fig. 9C-E) we showed that
multicellular spheroids of HCT-8/R1/T31 cells, like these of
HCT-8/E8 cells, cannot be readily dissociated by repeated
pipetting. 
DISCUSSION
On the basis of sequence database analysis we discovered a
novel member of the a -catenin family. Starting from a single
EST clone derived from testis mRNA, a novel full-length
cDNA was cloned, which we called a T-catenin. The encoded
novel protein has about the same predicted size as other a -
catenins (100 kDa) and shows an overall amino acid identity
of 57%. When the three main vinculin homology domains
previously proposed (Herrenknecht et al., 1991) were
separately aligned, the highest sequence conservation was
found in the C-terminal domain (Fig. 1B; 71.5% identity). It
is noteworthy that the sequence conservation between the
three presently known a -catenins is particularly elevated in
some functional domains, such as binding sites for b -catenin,
a -actinin and actin. Hence, a T-catenin is probably
able to function as a typical a -catenin. In line with this
observation, we demonstrated binding of a T-catenin
to b -catenin by coimmunoprecipitation. 
The 3D structure of an N-terminal fragment of the
a E-catenin protein was resolved recently and shown
to consist of antiparallel a -helices, which together
form a four-helix bundle either by homodimerization
or by binding to b -catenin (Pokutta and Weis, 2000).
A typical feature of this a E-catenin structure is a
tandem kink of 30°, generated by two proline
residues in helices a 3 and a 4, respectively (marked
by [P] in Fig. 1A). It is noteworthy that such proline
residues are completely absent from the a N-catenin
protein sequence, while only one is present in the a T-
catenin sequence. The domain for binding to b -
catenin is located in the very N-terminal part of a -
catenins. Although it was reported that a small
fragment, corresponding to a -helix-2a (Fig. 1A), can
bind to b -catenin (Huber et al., 1997), it was more
recently proposed on the basis of the 3D structure of
the a E -catenin fragment, that a -helix-0 is also
needed for binding to b -catenin (Pokutta and Weis,
2000). The amino acid sequences of both a -helix-0
and a -helix-2a seem to be well conserved across the
three a -catenin types, along with their ability to bind
to b -catenin. 
As shown by RT-PCR and immunoblotting
analysis, a T-catenin shows a restricted tissue-specific
expression pattern, with remarkably abundant mRNA
levels in heart and testis. Protein levels were
particularly high in heart. In addition, specific
transcripts were detected in brain and skeletal muscle
of both man and mouse, and in tongue, uterus and
ovary of mouse; this was confirmed at the protein
level. Some discrepancy was observed between
mRNA expression levels in kidney and liver of man
versus mouse. This could be due partly to species
differences. A wide variety of cell lines was checked
by RT-PCR and western blotting, but all lacked detectable a T-
catenin (data not shown). Overall, our expression analysis
showed clearly that a T-catenin is more tissue-specific than
a E-catenin or b -catenin, although less tissue-restricted than
a N-catenin. The expression of a T-catenin in heart is
particularly striking. In this context, it is remarkable that
metavinculin, a member of the a -catenin/vinculin family, is
Table 2. Kolmogoronov-Smirnov test for statistical
differences between fast aggregation curves
Curve 1 Curve 2 KS 1* KS 2*
t0 HCT-8/R1 t30 HCT-8/R1 531 236
t30 HCT-8/R1 t30 HCT-8/R1 + MB2 718 270
t0 HCT-8/E8 t30 HCT-8/E8 3976 2958
t30 HCT-8/E8 t30 HCT-8/E8 + MB2 3511 3541
t0 HRpCa N2 t30 HRpCa N2 1610 2040
t30 HRpCa N2 t30 HRpCa N2 + MB2 1840 1720
t0 HCT-8/R1/T31 t30 HCT-8/R1/T31 3560 3580
t30 HCT-8/R1/T31 t30 HCT-8/R1/T31 + MB2 4020 3911
*Kolmogoronov-Smirnov values (KS) higher than 1000 correspond to a
significant difference between curves (p=0.001); KS 1 and KS 2 are derived
from two independent experiments.
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Fig. 8. Fast aggregation of a -catenin-negative HCT-8/R1 colon cancer cells is
restored upon stable transfection with a T-catenin cDNA. After preparation of
single-cell suspensions, cell aggregation was measured by determination of the
volume distribution (%) in function of the particle diameter (m m) at the starting
point (t0) and after 30 minutes (t30). HCT-8/R1, HCT-8/E11R1 and HCT-8/E8
cells were all obtained by subcloning HCT-8 cells, but only HCT-8/E8 cells
express endogenous a E-catenin. HRpCa N2 is a cloned transfectant of HCT-
8/E11R1 cells expressing exogenous a N-catenin (van Hengel et al., 1997);
HCT-8/R1/T31 is a cloned transfectant of HCT-8/R1 cells expressing
exogenous a T-catenin. MB2 is a monoclonal E-cadherin blocking antibody.
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specifically expressed in cardiac and smooth muscle (Belkin
et al., 1988; Gimona et al., 1987). 
The polyclonal and monoclonal antibodies generated by us
against a T-catenin peptides turned out to be specific without
crossreaction with a E-catenin or a N-catenin. Likewise, all a -
catenin-specific antibodies tested hardly crossreacted with a T-
catenin protein in western blot analyses. This means that in all
previously reported analyses of adhesion complexes, including
the specialized intercalated discs between individual heart
muscle cells, a T-catenin protein was probably not detected.
The availability of a T-catenin-specific antibodies without
crossreactivity will allow previous findings to be re-evaluated.
In intercalated discs N-cadherin is the most important junction
molecule (Volk and Geiger, 1984; Volk and Geiger, 1986). N-
cadherin is known to be linked at its cytoplasmic site to b -
catenin or plakoglobin (Hertig et al., 1996), but much less is
known about the particular link between this complex and
the actin cytoskeleton, more particularly the heart-specific
myofibrils. It has been suggested that this link is very
important, as plakoglobin null-mutant embryos die from
embryonic day 10.5 onwards, owing to an impairment in the
architecture of myocardiac intercalated discs (Bierkamp et al.,
1996; Ruiz et al., 1996). We detected colocalization of a E- and
a T-catenins in intercalated discs.
In human testis cryosections, we detected a T-catenin protein
in peritubular myoid cells. Interestingly, a E-catenin is not co-
localizing here with a T-catenin as it is present in intratubular
cells. This differential localization points towards a specific
function for a T-catenin. It was shown for peritubular myoid
cells in the mouse that they express P-cadherin and b -catenin
at their cell membranes from day 15 after birth (Lin and
DePhilip, 1996), when actin filaments are fully organized in a
characteristic orthogonal pattern (Vogl et al., 1995). In
maturating peritubular cells of the rat, a E- and b -catenin were
detected but not plakoglobin (Byers et al., 1994). We may
propose a role for a T-catenin in the formation of a complex
between P-cadherin and F-actin, thus stabilizing the cell-cell
contacts between testicular peritubular myoid cells. 
To show functionality of a T-catenin in cell-cell adhesion
complexes, expression of ectopic a T-catenin in HCT-8/R1
cells lacking a -catenins was found to functionally restore
adhesive properties. Vaccinia virus-mediated transient
overexpression of a T-catenin in these cells clearly resulted in
recruitment of b -catenin to cell-cell contact sites. Stable
transfection with a plasmid encoding Myc-tagged a T-catenin
resulted in restoration of the cadherin-based adhesion
complex, but also of structures resembling tight junctions and
desmosomes. We showed restoration of strong cell-cell
adhesiveness in both fast and slow aggregation assays. Thus,
we showed that a T-catenin, like a E- and a N-catenin,
functions in cadherin-mediated cell-cell adhesion by
providing the necessary link between b -catenin and the actin
cytoskeleton. 
The fact that a T-catenin co-immunoprecipitated with b -
catenin from testis and heart tissues points towards a specific
function in adhesion complexes of these tissues. The relevance
of co-expression of a T- and a E-catenin in cardiomyocytes
remains to be elucidated. It is conceivable that stronger
anchoring of adhesion complexes to the actin cytoskeleton is
needed in heart muscle tissues, where a T-catenin is mainly
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Fig. 9. Slow aggregation, compaction and decompaction assays on various related HCT-8 colon cancer cells. (A) Representative
immunofluorescent staining for a -catenins in the cell lines used: no expression in untransfected HCT-8/R1 cells (R1), strong expression of a E-
catenin in untransfected HCT-8/E8 cells (E8), and moderate expression of exogenous a T-catenin in transfectant HCT-8/R1/T31 (T31).
(B) After slow aggregation of single-cell suspensions for 24 hours on semi-solid agar, images of representative cultures were taken. No
aggregation is seen in cultures of HCT-8/R1 cells. Cells expressing exogenous a T-catenin form compacted large aggregates, similar to those of
cells expressing endogenous a E-catenin. (C-D) Compaction-decompaction assays. (C) After Gyrotory shaking of suspended cell cultures for 3
days, cell aggregates were similar to the results obtained in (B). (D) Small spheroids of HCT-8/R1 cells were dissociated by repeated pipetting,
whereas no decompaction could be seen of larger spheroids of HCT-8/E8 and HCT-8/R1/T31 cells. (E) Quantification of compaction/
decompaction by volume distribution in function of the particle diameter: unbroken line, before compaction; dashed line, compaction; dotted
line, decompaction after pipetting. 
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expressed. a T-catenin may reinforce the cell-cell adhesion
junctions by forming molecular complexes similar to but
tighter than those containing a E-catenin. Furthermore, it is
possible that a T-catenin distinguishes itself from other a -
catenins by binding to specific interaction partners. 
In summary, we report an interesting novel member of the
a -catenin family. Although a T-catenin can be detected in the
same tissues as a E-catenin, enriched levels, especially in
cardiomyocytes and testicular peritubular myoid cells, point at
a crucial role in tissue-specific cell-cell adhesion junctions.
Introduction of ectopic a T-catenin in carcinoma cells with
defective a E-catenin expression restores functional cadherin-
catenin complexes. Further analysis of a T-catenin may
contribute to understanding how particular tissues achieve
different ways of cell-cell adhesion by use of specific a -
catenins. It will be challenging to discover a T-catenin-specific
binding partners and functions that are not shared by the other
a -catenins.
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